Agile Therapeutics Inc. diskutieren
Agile Therapeutics Inc.
WKN: A3D7A3 / Symbol: AGRX / Name: Agile Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,21 €
-
Agile Therapeutics, Inc. (NASDAQ: AGRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for AGRX provided by MarketBeat
Agile Therapeutics, Inc. (NASDAQ: AGRX) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Ratings data for AGRX provided by MarketBeat
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AGRX provided by MarketBeat
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AGRX provided by MarketBeat
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AGRX provided by MarketBeat
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AGRX provided by MarketBeat
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AGRX provided by MarketBeat
Neueste Beiträge
Glj_Research in Canadian Solar Inc. diskutieren